All these findings highlighted p53/p21 signaling as a potential downstream pathway of EVAVL1, which are regulated by BCAR4/miR-139-3p participating in cell apoptosis in ESCC progression. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.